1[1]Bataller, Sort P, Gines P, et al. Hepatorenal syndrome: definition, pathophysiology, clinical features and management . Kidney Int, 1998,53 (Suppl 66):S47
2[2]Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology, 1996,23(1):164
3[3]Guevara M, Gines p, Hadengue A,et al. Reversibility of hepato renal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology, 1998,27(1):35
4[4]Gulberg V, Bilzer M, Gerbes AL. Long-term therapy and retreatment of hepatorenal syndrome type I with ornipressin and dopamine. Hepatology,1999,30(4):870
5[5]Duhamel C, Mauillon J, Berkelmans I, et al. Hepatorenal sydrome: beneficial effect of terlipressin; propranolol treatment:a precipitation factor? Gut, 1999,45(Suppl V):A 217
6[6]Hadengue A, Gadano A, Moreau R, et al . Beneficial effect of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol, 1998;29(4):565
7[7]Brensing KA. Hepatorenal Syndrome.Lancet,1997,349(9053):697
